CD4 and tuberculosis: Patients who started second-line ART at age >45 years were 3.3 times (AHR = 3.33, 95% CI = 1.33–8.31) more likely to develop treatment failure compared to patients in the age group of 15–29 years after adjusting for the effect of WHO stage, TB status, CD4 count and adherence.